ketotifen has been researched along with Diabetes Mellitus in 3 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, J | 1 |
Shi, GP | 1 |
Dolecek, R | 1 |
3 other studies available for ketotifen and Diabetes Mellitus
Article | Year |
---|---|
Mast cell stabilization: novel medication for obesity and diabetes.
Topics: Animals; Cromolyn Sodium; Diabetes Mellitus; Insulin Resistance; Ketotifen; Mast Cells; Mice; Obesit | 2011 |
Ketotifen in the treatment of diabetics with various allergic conditions.
Topics: Biguanides; Blood; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Female; Glucose Tol | 1981 |
Rosiglitazone maleate. Ketotifen fumarate.
Topics: Conjunctivitis, Allergic; Diabetes Mellitus; Drug Administration Schedule; Histamine H1 Antagonists; | 1999 |